Antibiotic treatment for patients aged 15 years and older with moderate cellulitis funded by ACC. Oral antibiotic therapy is the preferred option.

The ACC MRI pathways support GPs and nurse practitioners to make direct referrals for MRIs, for eligible patients who have had a course of active physiotherapy.

This programme provides funding for Aclasta infusions for eligible patients. The infusion is to be provided in the community by the patient’s general practice.  

Antibiotic treatment for patients aged 15 years and older with moderate cellulitis. Oral antibiotic therapy is the preferred option.

Treatment of adults with suspicion of pathological fracture where there is no history of injury and children aged 8-16 years for suspicion of SUFE (unexplained hip, or knee pain, especially if the hip is internally rotated and flexed).

Antibiotic treatment for patients aged 15 years and older with moderate cellulitis funded by ACC. Oral antibiotic therapy is the preferred option.

The ACC MRI pathways support GPs and nurse practitioners to make direct referrals for MRIs, for eligible patients who have had a course of active physiotherapy.

Antibiotic treatment for patients aged 15 years and older with moderate cellulitis. Oral antibiotic therapy is the preferred option.

Treatment of adults with suspicion of pathological fracture where there is no history of injury and children aged 8-16 years for suspicion of SUFE (unexplained hip, or knee pain, especially if the hip is internally rotated and flexed).

This programme provides funding for Zoledronic acid infusions for patients who meet the PHARMAC special authority criteria for administration.

Antibiotic treatment for patients aged 15 years and older with moderate cellulitis funded by ACC. Oral antibiotic therapy is the preferred option.

The ACC MRI pathways support GPs and nurse practitioners to make direct referrals for MRIs, for eligible patients who have had a course of active physiotherapy.